Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nitric oxide and cancer: an introduction.

Literature DB >> 12684080

Nitric oxide and cancer: an introduction.

David A Wink¹, James B Mitchell.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2003 PMID： 12684080 DOI： 10.1016/s0891-5849(02)01362-x

Source DB: PubMed Journal: Free Radic Biol Med ISSN： 0891-5849 Impact factor: 7.376

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Characterization of C-alkyl amidines as bioavailable covalent reversible inhibitors of human DDAH-1.

Authors: Matthew Lluis; Yun Wang; Arthur F Monzingo; Walter Fast; Jon D Robertus
Journal: ChemMedChem Date: 2011-01-03 Impact factor: 3.466

2. Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.

Authors: Astrid Weyerbrock; Stuart Walbridge; Joseph E Saavedra; Larry K Keefer; Edward H Oldfield
Journal: Neuro Oncol Date: 2010-11-01 Impact factor: 12.300

3. Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide.

Authors: Yun Wang; Arthur F Monzingo; Shougang Hu; Tera H Schaller; Jon D Robertus; Walter Fast
Journal: Biochemistry Date: 2009-09-15 Impact factor: 3.162

4. Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.

Authors: Jonathan M Fahey; Albert W Girotti
Journal: Nitric Oxide Date: 2015-06-09 Impact factor: 4.427

10. Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs.

Authors: Harinath Chakrapani; Ravi C Kalathur; Anna E Maciag; Michael L Citro; Xinhua Ji; Larry K Keefer; Joseph E Saavedra
Journal: Bioorg Med Chem Date: 2008-09-30 Impact factor: 3.641

Nitric oxide and cancer: an introduction.

1. Characterization of C-alkyl amidines as bioavailable covalent reversible inhibitors of human DDAH-1.

2. Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.

3. Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide.

4. Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.

5. Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRI.

6. JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.

7. Role of nitric oxide and its metabolites as potential markers in lung cancer.

Review 8. NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.

9. Nitric oxide-dependent downregulation of BRCA1 expression promotes genetic instability.

10. Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs.